Thieme integrates Certara Chemaxon’s new generation chemical sketcher, Marvin, into its chemical databases Science of Synthesis and Pharmaceutical Substances

Chemaxon is a leading cheminformatics company that provides platforms, applications, and solutions to handle chemical entities in life sciences, biotechnology and other research industries. Certara acquired Chemaxon in 2024 to close gaps in the design-make-test-analyze cycle, bring promising leads into biosimulation, and speed up the launch of new medicines. Certara accelerates medicines using biosimulation software, technology and services to transform traditional drug discovery and development. Its clients include more than 2,600 biopharmaceutical companies, academic institutions, and regulatory agencies across 70 countries. Learn more at certara.com

Thieme is a leading provider of information and services for the improvement of health and healthcare. With digital solutions in medicine and chemistry, Thieme supports information, communication and documentation processes in science, education, and patient care. Thieme’s services are designed to be of direct benefit to their target groups – medical students, physicians, nurses, scientists, hospitals, health insurance companies, and other healthcare professionals. They receive exactly the information and services they need in a specific work situation or career. Together with a broad network of experts and partners, the digital healthcare provider ensures that it sets the pace in medical science, didactics, and technology. The family-owned company employs more than 1,000 people worldwide and is committed to improving medicine and health every day with innovative new and further developments. For more information about Thieme, please visit https://www.thieme.com.